Evidence map›Paper›PMID 40890813›Full record

ReviewInfectious agents and cancer2025

Prevalence and genotype distribution of human papillomavirus (HPV) infections among West African populations: a systematic review and meta-analysis.

Larwanou Harouna Magagi, Adamou Lagare, Arnol Bowo-Ngandji, Fatimata Hassane, Abdoulaye Zeidou Maiga, Moussa Issa, Alkassoum Ibrahim, Adehossi Eric, Alzouma Maiyaki Zoubeirou

Abstract readReview
In one paragraph

Review in Infectious agents and cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Larwanou Harouna MagagiCentre de Recherche Médicale et Sanitaire, 634 Boulevard de la Nation YN034, Niamey, BP: 10887, Niger. larwanoumagagi@gmail.com.
Adamou LagareCentre de Recherche Médicale et Sanitaire, 634 Boulevard de la Nation YN034, Niamey, BP: 10887, Niger.
Arnol Bowo-NgandjiDepartment of Microbiology, The University of Yaounde I, Yaounde, Cameroon.
Fatimata HassaneCentre de Recherche Médicale et Sanitaire, 634 Boulevard de la Nation YN034, Niamey, BP: 10887, Niger.
Abdoulaye Zeidou MaigaFaculté des Sciences de la Santé, Université Abdou Moumouni, Niamey, Niger.
Moussa IssaCentre de Recherche Médicale et Sanitaire, 634 Boulevard de la Nation YN034, Niamey, BP: 10887, Niger.
Alkassoum IbrahimFaculté des Sciences de la Santé, Université Abdou Moumouni, Niamey, Niger.
Adehossi EricFaculté des Sciences de la Santé, Université Abdou Moumouni, Niamey, Niger.
Alzouma Maiyaki ZoubeirouFaculté des Sciences et Techniques, Université Abdou Moumouni, Niamey, Niger.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. Several studies have examined HPV prevalence in West Africa, but comprehensive regional estimates remain unavailable. This study estimates the overall prevalence and genotype distribution of HPV in West African populations.

methodsWe conducted a systematic search in Medline, Embase, Global Health, Web of Science, and Africa Index Medicus for articles published up to March 5, 2024. We estimated pooled HPV prevalence using a random-effects model. The Hoy et al. tool assessed the risk of bias, while the I² test measured between-study heterogeneity. Egger's regression test evaluated publication bias. The study was registered with PROSPERO (CRD42023463042).

resultsThe analysis included 145 studies from 12 West African countries, comprising 71,324 participants. The pooled prevalence of HPV was 42.3% (95% CI: 38.5-46.1%), with significant heterogeneity (I² = 99.0%; P < 0.001). HPV prevalence varied across population subgroups, with a significantly higher pooled prevalence of 81.4% (95% CI: 68.2-91.8%) among women with cervical cancer. Egger's test did not indicate significant publication bias (P > 0.05). Among high-risk HPV genotypes, HPV-16 (19.9%, 95% CI: 15.9-24.1%) and HPV-82 (18.9%, 95% CI: 7.5-33.7%) were the most prevalent. Among low-risk genotypes, HPV-81 was the most common, with a prevalence of 12.9% (95% CI: 7.1-20.0%).

conclusionHuman papillomavirus prevalence is high in West Africa, with diverse genotypes, including several with oncogenic potential. Targeted health interventions, including vaccination programs and enhanced screening efforts, are recommended to reduce HPV burden in this region.

Indexed as

Genotype distributionHuman papillomavirusPrevalenceWest Africa

Identifiers

PMID40890813
PMCPMC12403902

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.